NanoBlood

NanoBlood LLC is dedicated to correcting insufficient blood flow by restoring endogenous nitric oxide (NO) without causing oxidative damage due to ischemia, reperfusion, and inflammation, thereby addressing unmet medical needs in diseases caused by excessive vascular superoxide production. The company has developed a 7-micron nanoparticle based on nitrosylated bovine hemoglobin stabilized with carbon monoxide and shielded with polyethylene glycol, which functions as a vascular dismutase mimetic [SanFlow aka PNPH (PolyNitrosylated Polyethylene Glycol Hemoglobin)].